|
Exhibit 2.1
E XECUTION
C OPY
AGREEMENT AND PLAN OF
MERGER
by and
among
PERKINELMER,
INC.
VICTOR ACQUISITION
CORP.
and
VIACELL,
INC.
Dated as of
October 1, 2007
TABLE OF
CONTENTS
|
|
|
|
|
| |
|
|
|
Page |
|
ARTICLE I THE CASH TENDER
OFFER
|
|
1 |
|
1.1
|
|
The Offer
|
|
1 |
|
1.2
|
|
Company Actions
|
|
3 |
|
1.3
|
|
Directors
|
|
4 |
|
|
|
ARTICLE II THE MERGER
|
|
5 |
|
2.1
|
|
The Merger
|
|
5 |
|
2.2
|
|
Closing
|
|
5 |
|
2.3
|
|
Effective Time
|
|
5 |
|
2.4
|
|
Effects of the Merger
|
|
6 |
|
2.5
|
|
Certificate of Incorporation and
By-Laws
|
|
6 |
|
2.6
|
|
Directors and Officers
|
|
6 |
|
2.7
|
|
Top-Up Option
|
|
6 |
|
|
|
ARTICLE III CONVERSION OF SECURITIES
IN THE MERGER
|
|
7 |
|
3.1
|
|
Effect of Merger of Capital
Stock
|
|
7 |
|
3.2
|
|
Surrender of Certificates
|
|
8 |
|
|
|
ARTICLE IV REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
|
|
10 |
|
4.1
|
|
Organization, Standing and
Power
|
|
10 |
|
4.2
|
|
Capitalization
|
|
11 |
|
4.3
|
|
Subsidiaries
|
|
12 |
|
4.4
|
|
Authority; No Conflict; Required Filings
and Consents
|
|
13 |
|
4.5
|
|
SEC Filings; Financial Statements;
Information Provided
|
|
15 |
|
4.6
|
|
No Undisclosed Liabilities
|
|
16 |
|
4.7
|
|
Absence of Certain Changes or
Events
|
|
16 |
|
4.8
|
|
Taxes
|
|
16 |
|
4.9
|
|
Owned and Leased Real
Properties
|
|
17 |
|
4.10
|
|
Intellectual Property
|
|
18 |
|
4.11
|
|
Agreements, Contracts and Commitments;
Government Contracts
|
|
19 |
|
4.12
|
|
Litigation
|
|
20 |
|
4.13
|
|
Environmental Matters
|
|
20 |
|
4.14
|
|
Employee Benefit Plans
|
|
22 |
|
4.15
|
|
Compliance With Laws
|
|
23 |
|
4.16
|
|
Permits
|
|
26 |
|
4.17
|
|
Labor Matters
|
|
26 |
|
4.18
|
|
Insurance
|
|
26 |
|
4.19
|
|
Opinion of Financial Advisor
|
|
26 |
|
4.20
|
|
Section 203 of the DGCL Not
Applicable
|
|
27 |
|
4.21
|
|
Brokers; Schedule of Fees and
Expenses
|
|
27 |
|
4.23
|
|
Rule 14d-10
|
|
27 |
|
4.24
|
|
Controls and Procedures, Certifications
and Other Matters Relating to the Sarbanes Act
|
|
27 |
|
|
|
ARTICLE V REPRESENTATIONS AND
WARRANTIES OF THE PARENT AND THE PURCHASER
|
|
28 |
|
5.1
|
|
Organization, Standing and
Power
|
|
28 |
|
5.2
|
|
Authority; No Conflict; Required Filings
and Consents
|
|
28 |
|
5.3
|
|
Information Provided
|
|
29 |
|
5.4
|
|
Interim Operations of the
Purchaser
|
|
29 |
|
5.5
|
|
Absence of Litigation
|
|
29 |
|
5.6
|
|
Availability of Funds
|
|
30 |
i
TABLE OF
CONTENTS
(Continued)
|
|
|
|
|
| |
|
|
|
Page |
|
5.7
|
|
Not An Interested Person
|
|
30 |
|
5.8
|
|
Other Agreements and
Understandings
|
|
30 |
|
5.9
|
|
Brokers
|
|
30 |
|
|
|
ARTICLE VI CONDUCT OF
BUSINESS
|
|
30 |
|
6.1
|
|
Conduct Prior to Effective
Time
|
|
30 |
|
6.2
|
|
Confidentiality
|
|
33 |
|
|
|
ARTICLE VII ADDITIONAL
AGREEMENTS
|
|
33 |
|
7.1
|
|
No Solicitation
|
|
33 |
|
7.2
|
|
Efforts; Consents, Notices and
Approvals
|
|
36 |
|
7.3
|
|
Notification of Certain
Matters
|
|
36 |
|
7.4
|
|
Company Stockholder Approval of the
Merger
|
|
37 |
|
7.5
|
|
Access to Information;
Confidentiality
|
|
38 |
|
7.6
|
|
Public Disclosure
|
|
38 |
|
7.7
|
|
Indemnification
|
|
38 |
|
7.8
|
|
Employee Benefits Matters
|
|
39 |
|
7.9
|
|
Employee Stock Purchase Plan and 401(k)
Plan
|
|
40 |
|
7.10
|
|
Treatment of Company Warrants
|
|
40 |
|
7.11
|
|
Stockholder Litigation
|
|
40 |
|
7.12
|
|
Parent Guaranty
|
|
41 |
|
|
|
ARTICLE VIII
CONDITIONS
|
|
41 |
|
8.1
|
|
Conditions to Obligation of Each Party
to Effect the Merger
|
|
41 |
|
|
|
ARTICLE IX TERMINATION, AMENDMENT AND
WAIVER
|
|
41 |
|
9.1
|
|
Termination
|
|
41 |
|
9.2
|
|
Effect of Termination
|
|
43 |
|
9.3
|
|
Fees and Expenses
|
|
43 |
|
9.4
|
|
Amendment
|
|
43 |
|
9.5
|
|
Extension; Waiver
|
|
43 |
|
9.6
|
|
Procedure for Termination, Amendment,
Extension or Waiver
|
|
43 |
|
|
|
ARTICLE X
MISCELLANEOUS
|
|
44 |
|
10.1
|
|
Nonsurvival of Representations and
Warranties
|
|
44 |
|
10.2
|
|
Notices
|
|
44 |
|
10.3
|
|
Entire Agreement
|
|
45 |
|
10.4
|
|
No Third Party Beneficiaries
|
|
45 |
|
10.5
|
|
Assignment
|
|
45 |
|
10.6
|
|
Severability
|
|
45 |
|
10.7
|
|
Counterparts and Signature
|
|
45 |
|
10.8
|
|
Interpretation
|
|
45 |
|
10.9
|
|
Governing Law
|
|
46 |
|
10.10
|
|
Remedies
|
|
46 |
|
10.11
|
|
Submission to Jurisdiction
|
|
46 |
|
10.12
|
|
WAIVER OF JURY TRIAL
|
|
46 |
|
|
|
|
ANNEX I
|
|
Conditions of The Offer |
|
EXHIBIT A
|
|
Form of
Certificate of Incorporation of the Surviving
Corporation |
ii
TABLE OF DEFINED
TERMS
|
|
|
|
Acceptance Time
|
|
1.3(a) |
|
Accredited Investor
|
|
2.7(d) |
|
Acquisition Agreement
|
|
7.1(b) |
|
Acquisition Proposal
|
|
7.1 |
|
Adverse Recommendation Notice
|
|
7.1(b) |
|
Affiliate
|
|
4.2(e) |
|
Agreement
|
|
Introduction |
|
Approved Company Compensation
Arrangement
|
|
4.23 |
|
Certificate of Merger
|
|
2.3 |
|
Certificate
|
|
3.1(a) |
|
CLIA
|
|
4.15(o) |
|
Closing
|
|
2.2 |
|
Closing Date
|
|
2.2 |
|
Code
|
|
1.1(e) |
|
Company
|
|
Introduction |
|
Company Adverse Recommendation
Change
|
|
9.1(c) |
|
Company Balance Sheet
|
|
4.5(b) |
|
Company Board
|
|
1.2(b) |
|
Company Capital Stock
|
|
3.2(c) |
|
Company Common Stock
|
|
Introduction |
|
Company Compensation
Arrangement
|
|
4.23 |
|
Company Disclosure Schedule
|
|
Article
IV |
|
Company Employees
|
|
7.8(a) |
|
Company Employee Plans
|
|
4.14(a) |
|
Company Intellectual Property
|
|
4.10(b) |
|
Company Leases
|
|
4.9(b) |
|
Company Material Adverse
Effect
|
|
4.1 |
|
Company Material Contracts
|
|
4.11(a) |
|
Company Permits
|
|
4.16 |
|
Company Preferred Stock
|
|
4.2(a) |
|
Company SEC Documents
|
|
4.5(a) |
|
Company Stockholder Approval
|
|
4.4(a) |
|
Company Stockholders Meeting
|
|
7.4(a) |
|
Company Stock Options
|
|
4.2(c) |
|
Company Stock Plans
|
|
4.2(c) |
|
Company Voting Proposal
|
|
4.4(a) |
|
Company Warrants
|
|
4.2(d) |
|
Compensation Committee
|
|
4.23 |
|
Confidentiality Agreement
|
|
6.2 |
|
Contamination
|
|
4.12(c) |
|
Designated SEC Documents
|
|
Article
IV |
|
DGCL
|
|
Introduction |
|
Dissenting Shares
|
|
3.1(b) |
|
Effective Time
|
|
2.3 |
|
Employee Benefit Plan
|
|
4.14(a) |
|
Environmental Law
|
|
4.13(b) |
|
ERISA
|
|
4.14(a) |
|
ERISA Affiliate
|
|
4.14(a) |
|
Exchange Act
|
|
1.1 |
|
ESPP
|
|
7.9 |
iii
TABLE OF DEFINED
TERMS
(Continued)
|
|
|
|
FDA
|
|
4.15(d) |
|
Financial Advisor
|
|
4.19 |
|
GAAP
|
|
4.5(b) |
|
Governmental Entity
|
|
4.4(c) |
|
Hazardous Substance
|
|
4.13(e) |
|
Healthcare-Related Law
|
|
4.15(o) |
|
HIPAA
|
|
4.15(i) |
|
HSR Act
|
|
4.4(c) |
|
Indemnified Parties
|
|
7.7(a) |
|
Independent Directors
|
|
1.3(c) |
|
Insurance Policies
|
|
4.18 |
|
Intellectual Property
|
|
4.10(a) |
|
Intervening Event
|
|
7.1(b) |
|
IRS
|
|
4.14(b) |
|
Letter of Transmittal
|
|
1.1(c) |
|
Liens
|
|
4.4(b) |
|
Merger
|
|
Introduction |
|
Merger Agreement
|
|
Annex
I |
|
Merger Consideration
|
|
3.1 |
|
Minimum Condition
|
|
Annex
I |
|
New Plans
|
|
7.8(b) |
|
Offer
|
|
Introduction |
|
Offer Consideration
|
|
1.1 |
|
Offer to Purchase
|
|
1.1 |
|
Offer Documents
|
|
1.1(c) |
|
Old Plans
|
|
7.8(b) |
|
Option Consideration
|
|
7.8(c) |
|
Ordinary Course of Business
|
|
4.3(d) |
|
Outside Date
|
|
9.1(b) |
|
Parent
|
|
Introduction |
|
Paying Agent
|
|
3.2(a) |
|
Payment Fund
|
|
3.2(a) |
|
Proxy Statement
|
|
7.4(b) |
|
Purchaser
|
|
Introduction |
|
Purchaser Designees
|
|
1.3(a) |
|
Registered Intellectual
Property
|
|
4.10(c) |
|
Registrations
|
|
4.15(d) |
|
Release
|
|
4.13(d) |
|
Representatives
|
|
7.1(a) |
|
Sarbanes Act
|
|
4.5(a) |
|
Schedule TO
|
|
1.1(c) |
|
Schedule 14D-9
|
|
1.2(b) |
|
SEC
|
|
1.1(b) |
|
Securities Act
|
|
4.2(e) |
|
Section 262
|
|
3.1(b) |
|
Shares
|
|
Introduction |
|
Specified Time
|
|
7.1(a) |
|
Stark Law
|
|
4.15(j) |
|
Subsidiary
|
|
4.3(a) |
iv
TABLE OF DEFINED
TERMS
(Continued)
|
|
|
|
Superior Proposal
|
|
7.1(f) |
|
Surviving Corporation
|
|
2.1 |
|
Taxes
|
|
4.8(n) |
|
Tax Returns
|
|
4.8(n) |
|
Third Party Intellectual
Property
|
|
4.10(b) |
|
Top-Up Option
|
|
2.7(a) |
|
Top-Up Option Shares
|
|
2.7(a) |
|
Trade Secrets
|
|
4.10(a) |
v
AGREEMENT AND PLAN OF
MERGER
THIS AGREEMENT AND PLAN OF
MERGER (this “Agreement”), dated as of October 1,
2007, is among PerkinElmer, Inc., a Massachusetts corporation (the
“Parent”), Victor Acquisition Corp., a Delaware
corporation and a wholly owned subsidiary of the Parent (the
“Purchaser”), and ViaCell, Inc., a Delaware corporation
(the “Company”).
WHEREAS, the respective
Boards of Directors of the Parent, the Purchaser and the Company
have determined that it would be advisable and in the best
interests of their respective stockholders for the Parent to
acquire the Company upon the terms and subject only to the
conditions set forth in this Agreement;
WHEREAS, in furtherance of
such acquisition, the Purchaser will make a cash tender offer (as
it may be amended from time to time as permitted under this
Agreement, the “Offer”) to purchase all of the
Company’s issued and outstanding shares of common stock,
$0.01 par value per share (the “Company Common Stock”),
at a price of $7.25 per share, net to the seller in cash, without
interest thereon, upon the terms and subject to the conditions set
forth in this Agreement;
WHEREAS, to effectuate such
acquisition, following consummation of the Offer, the Purchaser
will be merged with and into the Company, with the Company
continuing as the surviving corporation in such merger (the
“Merger”);
WHEREAS, the Board of
Directors of the Company has by unanimous vote (i) determined
that the Offer and the Merger are fair to, and in the best interest
of, the Company and its stockholders; (ii) approved this
Agreement and the transactions contemplated hereby and thereby,
including the Offer and the Merger, in accordance with the General
Corporation Law of the State of Delaware (the “DGCL”)
and (iii) declared the advisability of this Agreement and
resolved to recommend that the holders of the Company Common Stock
tender their shares into and accept the Offer and adopt this
Agreement;
NOW, THEREFORE, in
consideration of the foregoing and the respective representations,
warranties, covenants and agreements set forth herein, the Parent,
the Purchaser and the Company agree as follows:
ARTICLE I
THE CASH TENDER
OFFER
1.1 The Offer
.
(a) Subject to the terms and
conditions of this Agreement, within ten business days of the day
on which the Purchaser’s intention to make the Offer is
publicly announced (which announcement will be made by the Parent
on October 1, 2007), the Purchaser shall commence (within the
meaning of Rule 14d-2 under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”)), the Offer to purchase
any and all outstanding shares of Company Common Stock at a price
of $7.25 per share, net to the seller in cash, without interest
thereon (the “Offer Consideration”). On the terms and
subject to the prior satisfaction or waiver (to the extent
permitted under this Agreement) of the conditions of the Offer and
this Agreement, the Purchaser shall accept for payment all shares
of Company Common Stock validly tendered and not properly withdrawn
pursuant to the Offer as soon as practicable after the expiration
of the Offer and shall pay for all such shares of Company Common
Stock promptly after acceptance. The obligation of the Parent and
the Purchaser to commence the Offer and to accept for payment and
pay for shares of Company Common Stock validly tendered in the
Offer and not properly withdrawn shall be subject only to the
conditions set forth in Annex I to this
Agreement.
(b) The initial expiration
date of the Offer shall be the 20th business day after commencement
of the Offer (determined in accordance with Rules 14d-1(g)(3) and
14d-2 under the Exchange Act). The Purchaser
expressly reserves the right,
subject to compliance with the Exchange Act, to waive, amend or
modify any term or condition of the Offer in its sole discretion;
provided , however , that, without the prior written
consent of the Company, the Purchaser shall not:
(i) change the form of
consideration payable in the Offer, decrease the Offer
Consideration or decrease the number of shares of Company Common
Stock sought pursuant to the Offer;
(ii) extend the expiration
date of the Offer except (A) as required by applicable law
(including for any period required by any rule, regulation,
interpretation or position of the United States Securities and
Exchange Commission (the “SEC”) or the staff thereof),
(B) that if, immediately prior to the scheduled expiration
date of the Offer (as it may be extended), any condition to the
Offer has not been satisfied or waived, the Purchaser may, in its
sole discretion, and shall at the request of the Company, extend
the expiration date of the Offer for one or more periods (not in
excess of ten business days each) but in no event later than
February 28, 2008 or (C) in connection with an increase
in the consideration to be paid pursuant to the Offer so as to
comply with applicable rules and regulations of the SEC;
(iii) waive the Minimum
Condition;
(iv) amend any material term
of the Offer in any manner materially adverse to holders of shares
of Company Common Stock or which would, individually or in the
aggregate, reasonably be expected to prevent or materially delay
the consummation of the Offer or prevent, materially delay or
materially impair the ability of the Parent and the Purchaser to
consummate the Offer, the Merger or the other transactions
contemplated by this Agreement; or
(v) impose any condition to
the Offer not set forth in Annex I .
The Purchaser may, without the consent
of the Company, elect to provide a subsequent offering period for
the Offer in accordance with Rule 14d-11 of the Exchange Act
following its acceptance for payment of shares of Company Common
Stock in the Offer. If immediately following the Acceptance Time
(as defined in Section 1.3(a)), the shares of Company Common
Stock validly tendered and not properly withdrawn pursuant to the
Offer constitute more than 80% but less than 90% of the Shares of
Company Common Stock outstanding at that time, then to the extent
requested by the Company, the Purchaser shall provide for a
subsequent offering period of at least 5 business days;
provided , however , that the Purchaser shall not be
required to provide for such subsequent offering period if it
notifies the Company that it intends to promptly exercise the
Top-Up Option (as defined in Section 2.7(a)), and that the
Purchaser does so. The Offer may be terminated prior to its
expiration date (as such expiration date may be extended and
re-extended in accordance with this Agreement) only if this
Agreement is validly terminated in accordance with its
terms.
(c) On the date of
commencement of the Offer, the Parent and the Purchaser shall file
with the SEC a Tender Offer Statement on Schedule TO (together with
all amendments and supplements thereto, the “Schedule
TO”) with respect to the Offer. The Schedule TO shall contain
an offer to purchase (the “Offer to Purchase”), a form
of the related letter of transmittal (the “Letter of
Transmittal”), and ancillary documents and instruments
pursuant to which the Offer will be made (collectively, together
with any supplements or amendments thereto, the “Offer
Documents”). The Parent and the Purchaser agree that the
Offer Documents shall comply in all material respects with the
requirements of applicable U.S. federal securities laws and, on the
date first filed with the SEC and on the date first published, sent
or given to the Company’s stockholders, shall not contain any
untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which
they were made, not misleading, except that no covenant, agreement,
representation or warranty is made by the Parent or the Purchaser
with respect to information supplied by the Company or any of its
stockholders in writing for inclusion or incorporation by reference
in the Offer Documents. The Parent and the Purchaser shall take all
steps necessary to cause the Offer Documents to be disseminated to
holders of shares of Company Common Stock, as and to the extent
required by applicable U.S. federal securities laws. Each of the
Parent, the Purchaser and the Company each shall promptly correct
any information provided by it for use in the Schedule TO or the
Offer Documents if and to the extent that
2
such information shall have
become false or misleading in any material respect, and the Parent
and the Purchaser shall take all steps necessary to amend or
supplement the Schedule TO and, as applicable, the Offer Documents
and to cause the Schedule TO as so amended and supplemented to be
filed with the SEC and the Offer Documents as so amended and
supplemented to be disseminated to holders of shares of Company
Common Stock, in each case as and to the extent required by
applicable U.S. federal securities laws. The Company and its
counsel shall be given reasonable opportunity to review and comment
upon the Offer Documents and any amendments thereto prior to the
filing thereof with the SEC or dissemination to the stockholders of
the Company. The Parent and the Purchaser shall provide the Company
and its counsel with a copy of any written comments or telephonic
notification of any oral comments the Parent, the Purchaser or
their counsel may receive from the SEC or its staff with respect to
the Offer promptly after the receipt thereof, shall consult with
the Company and its counsel prior to responding to any such
comments, and shall provide the Company and its counsel with a copy
of any written responses thereto and telephonic notification of any
oral responses thereto of the Parent or the Purchaser or their
counsel.
(d) The Parent shall provide
or cause to be provided to the Purchaser on a timely basis the
funds necessary to purchase any and all shares of Company Common
Stock that the Purchaser becomes obligated to purchase pursuant to
the Offer.
(e) The Purchaser shall be
entitled to deduct and withhold from the consideration otherwise
payable pursuant to the Offer such amounts as the Purchaser
reasonably determines that it is required to deduct and withhold
with respect to the making of such payment under the Internal
Revenue Code of 1986, as amended (the “Code”), or under
any other applicable law.
1.2 Company Actions
.
(a) The Company hereby
approves of and consents to the Offer, the Merger and the other
transactions contemplated by this Agreement.
(b) Contemporaneously with
the commencement of the Offer, if practicable, and otherwise
reasonably promptly (and in any event within two business days)
thereafter, the Company shall file with the SEC a
Solicitation/Recommendation Statement on Schedule 14D-9 with
respect to the Offer (together with all amendments and supplements
thereto, the “Schedule 14D-9”) and disseminate the
Schedule 14D-9, to the extent required by applicable U.S. federal
securities laws, to the stockholders of the Company. Except and to
the extent otherwise permitted pursuant to Section 7.1 below,
the Offer Documents and the Schedule 14D-9 shall contain the
recommendation of the board of directors of the Company (the
“Company Board”) in favor of the Offer and the adoption
of this Agreement and the transactions contemplated hereby,
including the Merger, and the Company hereby consents to the
inclusion in the Offer Documents of such recommendation. The
Company agrees that the Schedule 14D-9 shall comply in all material
respects with the requirements of applicable U.S. federal
securities laws and on the date first filed with the SEC and on the
date first published, sent or given to the Company’s
stockholders, shall not contain any untrue statement of a material
fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not
misleading, except that no covenant, agreement, representation or
warranty is made by the Company with respect to information
supplied by the Parent or the Purchaser in writing for inclusion or
incorporation by reference in the Schedule 14D-9. Each of the
Company, the Parent and the Purchaser each shall promptly correct
any information provided by it for use in the Schedule 14D-9 if and
to the extent that such information shall have become false or
misleading in any material respect, and the Company shall take all
steps necessary to amend or supplement the Schedule 14D-9 and to
cause the Schedule 14D-9 as so amended or supplemented to be filed
with the SEC and disseminated to the Company’s stockholders,
in each case as and to the extent required by applicable U.S.
federal securities laws. The Parent and its counsel shall be given
reasonable opportunity to review and comment upon the Schedule
14D-9 and any amendments thereto prior to the filing thereof with
the SEC or dissemination to stockholders of the Company, except to
the extent that any delay caused by such opportunity to review and
comment would be inconsistent with the fiduciary obligations of the
Company Board. The Company shall provide the Parent and its counsel
with a copy of
3
any written comments or
telephonic notification of any oral comments the Company or its
counsel may receive from the SEC or its staff with respect to the
Offer promptly after the receipt thereof, shall consult with the
Parent and its counsel prior to responding to any such comments,
and shall provide the Parent and its counsel with a copy of any
written responses thereto and telephonic notification of any oral
responses thereto of the Company or its counsel.
(c) The Company shall
promptly supply to the Parent and the Purchaser in writing, for
inclusion in the Schedule TO and the Offer Documents, all
information concerning the Company required under applicable U.S.
federal securities laws to be included in the Offer Documents or
that may be reasonably requested by the Parent and the Purchaser in
connection with the preparation of the Schedule TO or the Offer
Documents or their obligations hereunder.
(d) In connection with the
Offer, the Company shall instruct and cause its transfer agent to
promptly furnish to the Purchaser or its designed agent mailing
labels containing the names and addresses of the record holders of
the shares of Company Common Stock as of a recent date and of those
persons becoming record holders subsequent to such date and, to the
extent known, a list of the beneficial owners of the shares of
Company Common Stock as of a recent date, together with copies of
all security position listings and all other computer files and
other information in the Company’s possession or control
regarding the beneficial owners of such shares, and shall furnish
to the Purchaser such information and assistance (including updated
lists and information) as the Purchaser may reasonably request for
the purpose of communicating the Offer to the record and beneficial
owners of the shares of Company Common Stock. From and after the
date of this Agreement, all such information concerning the
Company’s record and, to the extent known, beneficial holders
shall be made available to the Purchaser. Subject to the
requirements of applicable laws and except for such steps as are
necessary to disseminate the Offer Documents and any other
documents necessary to consummate the Offer, the Parent and the
Purchaser shall, until consummation of the Offer, hold in
confidence the information contained in any of such labels and
lists, shall use such information only in connection with the
Offer, the Merger and the other transactions contemplated by this
Agreement and, if this Agreement shall be terminated in accordance
with Section 9.1, shall, upon request, deliver to the Company,
or destroy at the Purchaser’s election, all copies of such
information then in their possession or under their
control.
1.3 Directors
.
(a) Promptly after the first
time at which the Purchaser accepts for payment shares of Company
Common Stock pursuant to the Offer (the “Acceptance
Time”) satisfying the Minimum Condition, and from time to
time thereafter as shares of Company Common Stock are accepted for
payment and paid for by the Purchaser, the Purchaser shall be
entitled to designate such number of members of the Company Board
(the “Purchaser Designees”), rounded up to the nearest
whole number, as will give the Purchaser representation on the
Company Board equal to the product of the total number of members
of the Company Board (after giving effect to the directors elected
pursuant to this sentence) multiplied by the percentage that the
number of shares of Company Common Stock beneficially owned by the
Parent or the Purchaser at such time (including shares of Company
Common Stock so accepted for payment) bears to the total number of
shares of Company Common Stock then outstanding; provided that in
no event shall the Purchaser Designees constitute less than a
majority of the Company Board. In furtherance thereof, the Company
shall, upon the request of the Purchaser, use its reasonable best
efforts promptly (and in any event within one business day) either
to increase the size of the Company Board or to secure the
resignations of such number of the Company’s incumbent
directors, or both, as is necessary to enable the Purchaser
Designees to be so elected or appointed to the Company Board and
the Company shall take all actions available to the Company to
cause the Purchaser Designees to be so elected or appointed. At
such time, the Company shall, if requested by the Purchaser, also
take all action necessary to cause persons designated by the
Purchaser to constitute at least the same percentage (rounded up to
the next whole number) as is on the Company Board of (i) each
committee of the Company Board, (ii) each board of directors
(or similar body) of each subsidiary of the Company and
(iii) each committee (or similar body) of each such board. The
provisions of this Section 1.3
4
are in addition to and shall
not limit any rights which the Purchaser, the Parent or any of
their affiliates may have as a holder or beneficial owner of shares
of Company Common Stock as a matter of applicable law with respect
to the election of directors or otherwise.
(b) The Company shall take
all actions required in order to fulfill its obligations under
Section 1.3(a), including mailing to its stockholders the
information required by Section 14(f) of the Exchange Act and
Rule 14f-1 promulgated thereunder as part of the Schedule 14D-9,
provided that the Parent and the Purchaser have timely supplied to
the Company in writing any information with respect to the Parent
and the Purchaser and the Purchaser Designees to the extent
required by such Section 14(f) and Rule 14f-1, and Parent
shall be solely responsible for such information.
(c) Notwithstanding the
provisions of this Section 1.3, the parties hereto shall use
their respective reasonable best efforts to ensure that at least
two of the members of the Company Board shall, at all times prior
to the Effective Time (as defined in Section 2.3 hereof), be
directors of the Company who were directors of the Company on the
date hereof (the “Independent Directors”), provided
that, if there shall be in office less than two Independent
Directors for any reason, the Company Board shall cause the person
designated by the remaining Independent Director to fill such
vacancy who shall be deemed to be an Independent Director for all
purposes of this Agreement, or if no Independent Directors then
remain, the other directors of the Company then in office shall
designate two persons to fill such vacancies who will not be
directors, officers, employees or affiliates of the Parent or the
Purchaser and such persons shall be deemed to be Independent
Directors for all purposes of this Agreement. From and after the
time, if any, that the Purchaser Designees constitute a majority of
the Company Board and prior to the Effective Time, subject to the
terms hereof, any amendment or modification of this Agreement, any
termination of this Agreement by the Company, any extension of time
for performance of any of the obligations of the Parent or the
Purchaser hereunder, any waiver of any condition to the
Company’s obligations hereunder or any of the Company’s
rights hereunder (other than a waiver of clause (A) of
Section 2.7(b)) or any amendment to the Company’s
certificate of incorporation or bylaws may be effected only if (in
addition to the approval of the Company Board as a whole) there are
in office one or more Independent Directors and such action is
approved by a majority of the Independent Directors then in
office.
ARTICLE II
THE
MERGER
2.1 The Merger . Upon
the terms and subject to the conditions set forth in this
Agreement, and in accordance with the DGCL, the Purchaser shall
merge with and into the Company at the Effective Time. At the
Effective Time, the separate corporate existence of the Purchaser
shall cease and the Company shall continue as the surviving
corporation (the “Surviving Corporation”) and shall
succeed to and assume all the rights and obligations of the
Purchaser in accordance with the DGCL.
2.2 Closing . Upon the
terms and subject to the conditions set forth in this Agreement,
the closing of the merger (the “Closing”) shall take
place at 11:00 a.m., eastern time, on the second business day after
the satisfaction or (to the extent permitted by applicable law)
waiver of the conditions set forth in Article VIII (other than
those that by their terms cannot be satisfied until the time of the
Closing but subject to the fulfillment or waiver of such
conditions), at the offices of Wilmer Cutler Pickering Hale and
Dorr LLP, 60 State Street, Boston, MA 02109, or at such other time,
date or place agreed to in writing by the Parent and the Company;
provided that if all the conditions set forth in Article VIII shall
not have been satisfied or (to the extent permitted by applicable
law) waived on such second business day, then the Closing shall
take place on the first business day on which all such conditions
shall have been satisfied or (to the extent permitted by applicable
law) waived. The date on which the Closing occurs is referred to in
this Agreement as the “Closing Date”.
2.3 Effective Time .
Upon the terms and subject to the conditions set forth in this
Agreement, as soon as practicable on the Closing Date, a
certificate of merger or other appropriate documents (in any such
case, the
5
“Certificate of Merger”)
shall be duly prepared, executed and acknowledged by the parties in
accordance with the relevant provisions of the DGCL and filed with
the Secretary of State of the State of Delaware. The Merger shall
become effective upon the filing of the Certificate of Merger with
the Secretary of State of the State of Delaware or at such
subsequent time or date as the Parent and the Company shall agree
and specify in the Certificate of Merger. The time at which the
Merger becomes effective is referred to in this Agreement as the
“Effective Time”.
2.4 Effects of the
Merger . The Merger shall have the effects set forth in
Section 259 of the DGCL.
2.5 Certificate of
Incorporation and By-Laws . The Certificate of Incorporation of
the Company as in effect on the date of this Agreement shall be
amended in its entirety to read as set forth in Exhibit A until
thereafter amended as provided under the DGCL. The By-laws of the
Purchaser as in effect immediately prior to the Effective Time
shall be the By-laws of the Surviving Corporation until thereafter
amended as provided under the DGCL.
2.6 Directors and
Officers . The directors of the Purchaser immediately prior to
the Effective Time will be the initial directors of the Surviving
Corporation, and the officers of the Company immediately prior to
the Effective Time will be the initial officers of the Surviving
Corporation, in each case until their successors are elected and
qualified. Prior to the Effective Time, the Company shall cause
each member of the Company Board, other than the Purchaser
Designees, to execute and deliver a letter effectuating his or her
resignation as a director of the Company effective upon the
Effective Time.
2.7 Top-Up Option
.
(a) Subject to
Section 2.7(b) and Section 2.7(c), the Company grants to
Purchaser an assignable and irrevocable option (the “Top-Up
Option”) to purchase from the Company the number of shares of
Company Common Stock (the “Top-Up Option Shares”) equal
to the number of shares of Company Common Stock that, when added to
the number of shares of Company Common Stock owned by Purchaser as
of immediately prior to the exercise of the Top-Up Option,
constitutes one share more than 90% of the number of shares of
Company Common Stock then outstanding on a fully diluted basis
(determined in accordance with Annex I ) (assuming the
issuance of the Top-Up Option Shares); provided ,
however , that the Top-Up Option shall not be exercisable
for a number of shares of Company Common Stock in excess of the
aggregate of the number of shares of Company Common Stock held as
treasury shares by the Company and its Subsidiaries and the number
of shares of Company Common Stock that the Company is authorized to
issue under its certificate of incorporation but that are not
issued and outstanding (and are not reserved for issuance pursuant
to the instruments disclosed pursuant to Section 4.2(d)) as of
immediately prior to the exercise of the Top-Up Option.
(b) The Top-Up Option may be
exercised by Purchaser, in whole or in part, at any time at or
after the Acceptance Time; provided , however , that
the obligation of the Company to deliver Top-Up Option Shares upon
the exercise of the Top-Up Option is subject to the conditions,
unless waived by the Company, that (A) the issuance of Top-Up
Option Shares pursuant to the Top-Up Option would not require
approval of the Company’s stockholders under applicable laws,
rules or regulations (including, without limitation, the NASDAQ
rules and regulations), (B) immediately following exercise of
the Top-Up Option, the number of shares of Company Common Stock
owned in the aggregate by the Parent, the Purchaser and each of the
Parent’s direct and indirectly wholly owned subsidiaries
constitutes at least one share more than 90% of the number of
shares of Company Common Stock then outstanding on a fully diluted
basis (determined in accordance with Annex I ) (assuming the
issuance of the Top-Up Option Shares) and (C) the Minimum
Condition shall have been satisfied. The parties shall cooperate to
ensure that the issuance of the Top-Up Option Shares is
accomplished consistent with all applicable laws, rules or
regulations, including compliance with an applicable exemption from
registration of the Top-Up Option Shares under the Securities Act.
The aggregate purchase price payable for the Top-Up Option Shares
shall be determined by multiplying the number of such Top-Up Option
Shares by the Offer Consideration. Such purchase price
may
6
be paid by Purchaser, at its
election, either in cash or by executing and delivering to the
Company a promissory note having a principal amount equal to such
purchase price, or by any combination of cash and such promissory
note. Any such promissory note shall bear interest at the
applicable federal rate determined under Section 1274(d) of
the Code, shall mature on the first anniversary of the date of
execution and delivery of such promissory note and may be prepaid
without premium or penalty.
(c) In the event that
Purchaser wishes to exercise the Top-Up Option, it shall deliver to
the Company a notice setting forth (i) the number of Top-Up
Option Shares that it intends to purchase pursuant to the Top-Up
Option, (ii) the manner in which it intends to pay the
applicable exercise price and (iii) the place and time at
which the closing of the purchase of the Top-Up Option Shares by
Purchaser is to take place. At the closing of the purchase of the
Top-Up Option Shares, Purchaser shall cause to be delivered to the
Company the consideration required to be delivered in exchange for
such Top-Up Option Shares, and the Company shall cause to be issued
to Purchaser a certificate representing such shares.
(d) Parent and Purchaser
acknowledge that the Top-Up Option Shares that Purchaser may
acquire upon exercise of the Top-Up Option will not be registered
under the Securities Act and will be issued in reliance upon an
exemption thereunder for transactions not involving a public
offering. Parent and Purchaser represent and warrant to the Company
that Purchaser is, or will be upon the purchase of the Top-Up
Option Shares, an “Accredited Investor”, as defined in
Rule 501 of Regulation D under the Securities Act. Purchaser agrees
that the Top-Up Option and the Top-Up Option Shares to be acquired
upon exercise of the Top-Up Option are being and will be acquired
by Purchaser for the purpose of investment and not with a view to,
or for resale in connection with, any distribution thereof in
violation of the Securities Act.
ARTICLE III
CONVERSION OF
SECURITIES IN THE MERGER
3.1 Effect of Merger of
Capital Stock .
(a) At the Effective Time, by
virtue of the Merger and without any action on the part of the
Purchaser, the Company, the Surviving Corporation or the holder of
any of the following securities:
(i) each share of the
Purchaser’s capital stock issued and outstanding immediately
prior to the Effective Time shall be converted into and become one
validly issued, fully paid and nonassessable share of the same
class of capital stock of the Surviving Corporation;
(ii) each share of Company
Common Stock issued and outstanding immediately prior to the
Effective Time that is owned by the Parent, the Purchaser or the
Company or any direct or indirect wholly-owned subsidiary of the
Parent, the Purchaser or the Company, including all shares of
Company Common Stock held by the Company as treasury stock, shall
automatically be cancelled and retired, and no payment shall be
made with respect thereto; and
(iii) each share of Company
Common Stock issued and outstanding immediately prior to the
Effective Time (other than shares of Company Common Stock to be
cancelled pursuant to clause (ii) above and any Dissenting
Shares (as defined in Section 3.1(b) hereof)) shall be
automatically cancelled and extinguished and be converted into and
become the right to receive from the Surviving Corporation $7.25 in
cash per share (or any such higher price per share as may be paid
in the Offer) without any interest thereon (the “Merger
Consideration”). As of the Effective Time, all such shares of
Company Common Stock shall no longer be outstanding and shall be
automatically cancelled and shall cease to exist, and each holder
of a certificate which immediately prior to the Effective Time
represented any such shares of Company Common Stock (each, a
“Certificate”) shall cease to have any rights with
respect thereto, except the right to receive the Merger
Consideration pursuant to this Section 3.1(a)(iii) upon
surrender of such Certificate in accordance with Section 3.2,
without interest and subject to any applicable withholding rights
in accordance with Section 3.2(h).
7
(b) Notwithstanding anything
in this Agreement to the contrary, shares (the “Dissenting
Shares”) of the Company’s Common Stock that are issued
and outstanding immediately prior to the Effective Time and that
are held by any holder who is entitled to demand and properly
demands appraisal of such shares pursuant to, and who complies in
all respects with, the provisions of Section 262 of the DGCL
(“Section 262”) shall not be converted into the right
to receive the Merger Consideration as provided in
Section 3.1(a)(iii), but instead such holder shall be entitled
to payment of the fair value of such Dissenting Shares in
accordance with the provisions of Section 262. At the
Effective Time, all Dissenting Shares shall no longer be
outstanding and shall automatically be cancelled and shall cease to
exist, and each holder of Dissenting Shares shall cease to have any
rights with respect thereto, except the right to receive the fair
value of such shares in accordance with the provisions of
Section 262. Notwithstanding the foregoing, if any such holder
shall fail to perfect or otherwise shall waive, withdraw or lose
the right to appraisal under Section 262 or a court of
competent jurisdiction shall determine that such holder is not
entitled to the relief provided by Section 262, then the right
of such holder to be paid the fair value of such holder’s
Dissenting Shares under Section 262 shall cease and such
Dissenting Shares shall be deemed to have been converted at the
Effective Time into, and shall have become, the right to receive
the Merger Consideration as provided in Section 3.1(a)(iii).
The Company shall give the Parent and the Purchaser prompt notice
of any demands for payment, or notices of intent to demand payment,
received by the Company with respect to shares of Company Common
Stock, and the Parent and the Purchaser shall have the right to
participate in and direct all negotiations and proceedings with
respect to such demands. Prior to the Effective Time, the Company
shall not, except with the prior written consent of the Parent and
the Purchaser, make any payment with respect to, or settle, or
offer to settle, any such demands, or agree to do any of the
foregoing.
(c) Following the Effective
Time, Company Stock Options and Company Warrants shall be treated
in the manner set forth in Section 7.8 and
Section 7.10.
3.2 Surrender of
Certificates .
(a) Prior to the Effective
Time, the Parent shall select a bank or trust company reasonably
acceptable to the Company to act as agent (the “Paying
Agent”) for the payment after the Effective Time of the
Merger Consideration upon surrender of Certificates. At or prior to
the Effective Time, the Parent shall provide, or cause the
Surviving Corporation to provide, to the Paying Agent, cash
necessary for payment of the Merger Consideration pursuant to
Section 3.1(a)(iii) upon surrender of Certificates (such cash
being hereinafter referred to as the “Payment
Fund”).
(b) Parent shall use its
reasonable best efforts to cause the Paying Agent to mail to each
holder of record of a Certificate within five business days after
the Effective Time (or, if reasonably practicable, sooner):
(i) a Letter of Transmittal (in customary form and which shall
specify that delivery shall be effected, and risk of loss and title
to the Certificate shall pass, only upon delivery of the
Certificate to the Paying Agent and shall be in such form and have
such other provisions as the Parent may reasonably specify) and
(ii) instructions for use in effecting the surrender of the
Certificate in exchange for the Merger Consideration. Upon
surrender of a Certificate for cancellation to the Paying Agent or
to such other agent or agents as may be appointed by the Parent,
together with such Letter of Transmittal, duly completed and
properly executed, and such other documents as may reasonably be
required by the Paying Agent, the holder of such Certificate shall
be entitled to receive in exchange therefor an amount of cash equal
to the Merger Consideration that such holder has the right to
receive pursuant to Section 3.1(a)(iii), and the Certificate
so surrendered shall forthwith be cancelled. In the event of a
transfer of ownership of Company Common Stock that is not
registered in the stock transfer records of the Company, payment
may be made to a person other than the person in whose name the
Certificate so surrendered is registered if such Certificate shall
be properly endorsed or otherwise be in proper form for transfer
and the person requesting such payment shall pay any transfer or
other taxes required by reason of the payment to a person other
than the registered holder of such Certificate or establish to the
satisfaction of the Parent that such tax has been paid or is not
applicable. Until surrendered as contemplated by this
Section 3.2, each Certificate shall be deemed at any time
after the Effective Time to represent only the right to receive
upon such surrender the amount of cash,
8
without interest, into which
the shares of Company Common Stock formerly represented by such
Certificate have been converted pursuant to
Section 3.1(a)(iii). No interest shall be paid or shall accrue
on the cash payable upon surrender of any Certificate.
(c) The Merger Consideration
paid upon the surrender of a Certificate in accordance with the
terms of this Article III shall be deemed to have been paid in
full satisfaction of all rights pertaining to the shares of the
capital stock of the Company (the “Company Capital
Stock”) formerly represented by such Certificate. Upon the
Effective Time, the stock transfer books of the Company shall be
closed, and there shall be no further registration of transfers on
the stock transfer books of the Surviving Corporation of shares of
Company Capital Stock that were outstanding immediately prior to
the Effective Time. If, after the Effective Time, any Certificates
are presented to the Surviving Corporation or the Paying Agent for
any reason, they shall be cancelled and exchanged as provided in
this Article III.
(d) Any portion of the
Payment Fund that remains undistributed to the holders of
Certificates for six months after the Effective Time shall be
delivered by the Paying Agent to the Parent, upon demand, and any
holder of a Certificate who has not theretofore complied with this
Article III shall thereafter look only to the Parent for
payment of the Merger Consideration, but shall have no greater
rights against the Parent than may be accorded to general unsecured
creditors of the Parent under applicable law.
(e) None of the Parent, the
Purchaser, the Company, the Surviving Corporation or the Paying
Agent shall be liable to any person in respect of any cash from the
Payment Fund delivered to a public official pursuant to any
applicable abandoned property, escheat or similar law. If any
Certificate has not been surrendered prior to two years after the
Effective Time (or immediately prior to such earlier date on which
the Merger Consideration in respect of such Certificate would
otherwise escheat to or become the property of any Governmental
Entity (as defined in Section 4.4)), any such cash in respect
of such Certificate shall, to the extent permitted by applicable
law, become the property of the Surviving Corporation, free and
clear of all claims or interest of any person previously entitled
thereto.
(f) The Paying Agent shall
invest any cash included in the Payment Fund in (i) direct
obligations of the United States of America, (ii) obligations
for which the full faith and credit of the United States of America
is pledged to provide for payment of all principal and interest,
(iii) commercial paper obligations receiving the highest
rating from either Moody’s Investor Services, Inc. or
Standard & Poor’s, a division of The McGraw Hill
Companies, or (iv) money market funds investing solely in a
combination of the foregoing, or a combination thereof, as directed
by and for the benefit of the Surviving Corporation;
provided , however , that no gain or loss thereon
shall affect the amounts payable hereunder and the Parent shall use
its reasonable best efforts to cause the Payment Fund to include at
all times cash necessary for payment of the Merger Consideration
pursuant to Section 3.1(a)(iii) upon surrender of
Certificates. Any interest and other income resulting from such
investments shall be paid to and be the property of the
Parent.
(g) If any Certificate shall
have been lost, stolen or destroyed, the Paying Agent shall pay to
such holder the Merger Consideration required pursuant to
Section 3.1(a)(iii), in exchange for such lost, stolen or
destroyed Certificate, upon the making of an affidavit of that fact
by the holder thereof with such assurances as the Parent, in its
discretion and as a condition precedent to the payment of the
Merger Consideration, may require of the holder of such lost,
stolen or destroyed Certificate.
(h) The Parent, the Surviving
Corporation and the Paying Agent shall be entitled to deduct and
withhold from the consideration otherwise payable pursuant to this
Agreement such amounts as any of them reasonably determines that it
is required to deduct and withhold with respect to the making of
such payment under the Code or any other applicable law. To the
extent that amounts are so withheld and paid over to the
appropriate taxing authority by the Parent, the Surviving
Corporation or the Paying Agent, such withheld amounts shall be
treated for all purposes of this Agreement as having been paid to
the holder of the shares of Company Common Stock in respect of
which such deduction and withholding was made by the Parent, the
Surviving Corporation or the Paying Agent.
9
ARTICLE IV
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
Except as set forth in the
disclosure schedule delivered by the Company to the Parent on or
before the date of this Agreement (the “Company Disclosure
Schedule”) (it being agreed that disclosure of any item in
any section of the Company Disclosure Schedule shall also be deemed
disclosure with respect to any other section of this Agreement, but
only to the extent that it is readily apparent from a reading of
such disclosure that it also qualifies or applies to such other
section to which such disclosure is relevant), or as disclosed in
the Company’s Annual Report on Form 10-K for the fiscal year
ended December 31, 2006, or any report filed with the SEC by
the Company pursuant to the Exchange Act after the date of filing
of such Form 10-K filed with the SEC on the SEC’s EDGAR
system at least three business days prior to the date hereof (other
than any information in the “Risk Factors” and
“Note Regarding Forward-Looking Statements” sections of
such Company SEC Documents, and other than any other
forward-looking statements contained in such Company SEC Documents
that are of a nature that they speculate about future developments)
(the “Designated SEC Documents”), the Company hereby
represents and warrants to the Parent and the Purchaser as
follows:
4.1 Organization, Standing
and Power . The Company is a corporation duly organized,
validly existing and in good standing under the laws of the
jurisdiction of its incorporation, has all requisite corporate
power and authority to own, lease and operate its properties and
assets and to carry on its business as now being conducted, and is
duly qualified to do business and is in good standing as a foreign
corporation in each jurisdiction listed in Section 4.1 of the
Company Disclosure Schedule, which jurisdictions constitute the
only jurisdictions in which the character of the properties it
owns, operates or leases or the nature of its activities makes such
qualification necessary, except for such failures to be so
organized, qualified or in good standing that have not had, and
would not reasonably be expected to result in, a Company Material
Adverse Effect. For purposes of this Agreement, the term
“Company Material Adverse Effect” means any change,
event, circumstance, development or effect that, individually or in
the aggregate with all other changes, events, circumstances,
developments or effects occurring or existing prior to the
determination of a Company Material Adverse Effect, has a material
adverse effect on (i) the business, assets, liabilities,
capitalization, condition (financial or other), or results of
operations of the Company and its Subsidiaries, taken as a whole or
(ii) the ability of the Company to consummate the transactions
contemplated by this Agreement; provided , however ,
that none of the following shall be deemed either alone or in
combination with any of the following to constitute a Company
Material Adverse Effect: (A) any adverse effect that results
from general economic, business, financial or market conditions
(provided that such adverse effect does not affect the Company and
its Subsidiaries, taken as a whole, in a disproportionate manner as
compared to the Company’s industry peers); (B) any
adverse effect that results from conditions in any of the
industries or industry sectors in which the Company or any of its
Subsidiaries operates (provided that such adverse effect does not
affect the Company and its Subsidiaries, taken as a whole, in a
disproportionate manner as compared to the Company’s industry
peers); (C) any adverse effect resulting from any act of
terrorism, war, national or international calamity or any other
similar event (provided that such adverse effect does not affect
the Company and its Subsidiaries, taken as a whole, in a
disproportionate manner as compared to the Company’s industry
peers); (D) any adverse effect resulting from any change in
any applicable United States or foreign, federal, state or local
laws, statutes, ordinances, rules, regulations or agency
requirements of any Governmental Entity, or regulatory requirements
(provided that such adverse effect does not affect the Company in a
disproportionate manner as compared to the Company’s industry
peers or as compared to the Parent); (E) any changes (after
the date hereof) in GAAP; (F) any loss of customers,
suppliers, vendors or employees or any cancellation of or delay in
customer orders resulting from the announcement or pendency of this
Agreement, the Offer or the Merger (but not, for the avoidance of
doubt, any direct legal or contractual consequence of the
Company’s execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated
hereby or thereby); (G) the failure of the Company to meet
internal or analysts’ expectations or projections, in and of
itself (it being understood that any cause of any such failure may
be deemed to constitute, in and of itself, a Company Material
Adverse Effect and may be taken into consideration when determining
whether a Company Material Adverse Effect has occurred);
(H) any adverse effect resulting from any action taken by the
Company or any of its Subsidiaries with Parent’s prior
written consent or the taking of any action
10
expressly required by this Agreement
(other than in the first sentence of Section 6.1); (I) a
decline in the Company’s stock price, in and of itself (it
being understood that any cause of any such decline may be deemed
to constitute, in and of itself, a Company Material Adverse Effect
and may be taken into consideration when determining whether a
Company Material Adverse Effect has occurred); and (J) the
Company’s continuing to suffer operating losses in amounts
not materially larger than the losses projected to be suffered by
the Company in projections previously provided to Parent by the
Company. For the avoidance of doubt, the parties agree that the
terms “material”, “materially” or
“materiality” as used in this Agreement with an initial
lower case “m” shall have their respective customary
and ordinary meanings, without regard to the meanings ascribed to
Company Material Adverse Effect in the prior sentence of this
paragraph. The Company has delivered to the Parent complete and
accurate copies of the Certificate of Incorporation and By-laws of
the Company.
4.2 Capitalization
.
(a) The authorized capital
stock of the Company consists of 100,000,000 shares of Company
Common Stock and 5,000,000 shares of preferred stock, $.01 par
value per share (“Company Preferred Stock”). The rights
and privileges of each class of the Company’s capital stock
are as set forth in the Company’s Certificate of
Incorporation. As of September 27, 2007, (i) 39,079,100
shares of Company Common Stock were issued and outstanding,
(ii) no shares of Company Common Stock were held in the
treasury of the Company or by Subsidiaries of the Company, and
(iii) no shares of Company Preferred Stock were designated,
issued or outstanding.
(b) The Company has made
available to the Parent complete and accurate list of all issued
and outstanding shares of Company Common Stock that constitute
restricted stock or that are otherwise subject to a repurchase or
redemption right or right of first refusal in favor of the Company,
indicating the name of the applicable stockholder, the vesting
schedule for any such shares, including the extent to which any
such repurchase or redemption right or right of first refusal has
lapsed as of the date of this Agreement, whether (and to what
extent) the vesting will be accelerated in any way by the
transactions contemplated by this Agreement or by termination of
employment or change in position following consummation of the
Merger, and whether such holder has the sole power to vote and
dispose of such shares.
(c) The Company has made
available to the Parent complete and accurate information, as of
the date of this Agreement, regarding all plans or other
arrangements under which Company Stock Options (as defined below)
were granted (collectively, the “Company Stock Plans”),
indicating for each Company Stock Plan, as of the close of business
on the business day prior to the date of this Agreement, the number
of shares of Company Common Stock issued to date under such Plan,
the number of shares of Company Common Stock subject to outstanding
options under such Plan (such outstanding options, the
“Company Stock Options”) and the number of shares of
Company Common Stock reserved for future issuance under such Plan.
The Company has made available to the Parent complete and accurate
copies of all Company Stock Plans and the forms of all stock option
agreements evidencing Company Stock Options.
(d) The Company has made
available to the Parent complete and accurate information regarding
the number of shares of Company Common Stock reserved for future
issuance pursuant to warrants or other outstanding rights to
purchase shares of Company Common Stock outstanding as of the date
of this Agreement (other than Company Common Stock) (such
outstanding warrants or other rights, the “Company
Warrants”) and the agreement or other document under which
such Company Warrants were granted and sets forth a complete and
accurate list of all holders of Company Warrants indicating the
number and type of shares of Company Common Stock subject to each
Company Warrant, and the exercise price and the date of grant
thereof. The Company has delivered to the Parent complete and
accurate copies of the forms of agreements evidencing all Company
Warrants.
(e) Except (x) as set
forth in this Section 4.2 and (y) as reserved for future
grants under Company Stock Plans, (i) there are no equity
securities of any class of the Company, or any security
exchangeable into or exercisable for such equity securities,
issued, reserved for issuance or outstanding and (ii) there
are no options, warrants, equity securities, calls, rights,
commitments or agreements of any character to which the
11
Company or any of its
Subsidiaries is a party or by which the Company or any of its
Subsidiaries is bound obligating the Company or any of its
Subsidiaries to issue, exchange, transfer, deliver or sell, or
cause to be issued, exchanged, transferred, delivered or sold,
additional shares of capital stock or other equity interests of the
Company or any security or rights convertible into or exchangeable
or exercisable for any such shares or other equity interests, or
obligating the Company or any of its Subsidiaries to grant, extend,
accelerate the vesting of, otherwise modify or amend or enter into
any such option, warrant, equity security, call, right, commitment
or agreement. The Company does not have any outstanding stock
appreciation rights, phantom stock, performance based rights or
similar rights or obligations. Neither the Company nor, to the
knowledge of the Company, any of its Affiliates, is a party to or
is bound by any agreements or other enforceable arrangements with
respect to the voting (including voting trusts and proxies) or sale
or transfer (including agreements imposing transfer restrictions)
of any shares of capital stock or other equity interests of the
Company. For purposes of this Agreement, the term
“Affiliate” when used with respect to any party shall
mean any person who is an “affiliate” of that party
within the meaning of Rule 405 promulgated under the Securities Act
of 1933, as amended (the “Securities Act”). Except as
contemplated by this Agreement, there are no registration rights,
and there is no rights agreement, “poison pill”
anti-takeover plan or other agreement or other enforceable
arrangements to which the Company or any of its Subsidiaries is a
party or by which it or they are bound with respect to any equity
security of any class of the Company.
(f) All outstanding shares of
Company Common Stock are, and all shares of Company Common Stock
subject to issuance as specified in Sections 4.2(c) and 4.2(d)
above, upon issuance on the terms and conditions specified in the
instruments pursuant to which they are issuable, will be, duly
authorized, validly issued, fully paid and nonassessable and not
subject to or issued in violation of any purchase option, call
option, right of first refusal, preemptive right, subscription
right or any similar right under any provision of the DGCL, the
Company’s Certificate of Incorporation or By-laws or any
agreement to which the Company is a party or is otherwise
bound.
(g) There are no obligations,
contingent or otherwise, of the Company or any of its Subsidiaries
to repurchase, redeem or otherwise acquire any shares of Company
Common Stock or the capital stock of the Company or any of its
Subsidiaries or to provide funds to or make any investment (in the
form of a loan, capital contribution or otherwise) in the Company
or any Subsidiary of the Company or any other entity, other than
guarantees of bank obligations of Subsidiaries of the Company made
available to the Parent by the Company.
(h) No consent of the holders
of Company Stock Options or Company Warrants is required in
connection with the actions contemplated by Sections 3.1(c) and
7.8.
4.3 Subsidiaries
.
(a) The Company has made
available to the Parent a complete and accurate list of each
Subsidiary of the Company, including: (i) its name;
(ii) the number and type of outstanding equity securities and
a list of the holders thereof; and (iii) the jurisdiction of
organization. For purposes of this Agreement, the term
“Subsidiary” means, with respect to any party, any
corporation, partnership, trust, limited liability company or other
non-corporate business enterprise in which such party (or another
Subsidiary of such party) holds stock or other ownership interests
representing (A) more that 50% of the voting power of all
outstanding stock or ownership interests of such entity or
(B) the right to receive more than 50% of the net assets of
such entity available for distribution to the holders of
outstanding stock or ownership interests upon a liquidation or
dissolution of such entity.
(b) Each Subsidiary of the
Company is a corporation duly organized, validly existing and in
good standing under the laws of the jurisdiction of its
incorporation, has all requisite corporate power and authority to
own, lease and operate its properties and assets and to carry on
its business as now being conducted, and is duly qualified to do
business and is in good standing as a foreign corporation in each
jurisdiction where the character of its properties owned, operated
or leased or the nature of its activities makes such qualification
necessary, except for such failures to be so organized, qualified,
in good standing
12
or to have such power and
authority that have not had, and would not reasonably be expected
to result in, a Company Material Adverse Effect. All of the
outstanding shares of capital stock and other equity securities or
interests of each Subsidiary of the Company are duly authorized,
validly issued, fully paid, nonassessable and free of preemptive
rights and all such shares (other than directors’ qualifying
shares in the case of non-U.S. Subsidiaries, all of which the
Company has the power to cause to be transferred for no or nominal
consideration to the Company or the Company’s designee) are
owned, of record and beneficially, by the Company or another of its
Subsidiaries free and clear of all security interests, liens,
claims, pledges, agreements, limitations in the Company’s
voting rights, charges or other encumbrances of any nature. There
are no outstanding or authorized options, warrants, rights,
agreements or commitments to which the Company or any of its
Subsidiaries is a party or which are binding on any of them
providing for the issuance, disposition or acquisition of any
capital stock of any Subsidiary of the Company. There are no
outstanding stock appreciation, phantom stock or similar rights
with respect to any Subsidiary of the Company. There are no voting
trusts, proxies or other agreements or understandings with respect
to the voting of any capital stock of any Subsidiary of the
Company.
(c) The Company has delivered
to the Parent complete and accurate copies of the charter, by-laws
or other organizational documents of each Subsidiary of the
Company.
(d) Other than pursuant to
the Company’s investment policy as in effect on the date of
this Agreement (a copy of which has been made available to the
Parent), the Company does not control directly or indirectly or
have any direct or indirect equity participation or similar
interest in any corporation, partnership, limited liability
company, joint venture, trust or other business association or
entity which is not a Subsidiary of the Company. There are no
obligations, contingent or otherwise, of the Company or any of its
Subsidiaries to repurchase, redeem or otherwise acquire any shares
of capital stock of any Subsidiary of the Company or to provide
funds to or make any investment (in the form of a loan, capital
contribution or otherwise) in any Subsidiary of the Company or any
other entity, other than guarantees of bank obligations of
Subsidiaries of the Company entered into in the ordinary course of
business consistent with past practice (the “Ordinary Course
of Business”).
4.4 Authority; No
Conflict; Required Filings and Consents .
(a) The Company has all
requisite corporate power and authority to enter into this
Agreement, perform its obligations hereunder and, subject only to
the adoption of this Agreement and the approval of the Merger (the
“Company Voting Proposal”) by the Company’s
stockholders under the DGCL (the “Company Stockholder
Approval”), to the extent required by applicable law, to
consummate the transactions contemplated by this Agreement. Without
limiting the generality of the foregoing, the Company Board, at a
meeting duly called and held, by the unanimous vote of all
directors (i) determined that the Merger, the Offer and this
Agreement are fair to and in the best interests of the Company and
its stockholders, (ii) approved the Merger, the Offer and this
Agreement and declared the advisability of this Agreement, and
(iii) directed that this Agreement be submitted to the
stockholders of the Company for their adoption and resolved to
recommend that the stockholders of the Company vote in favor of the
adoption of this Agreement, to the extent required by applicable
law. The execution and delivery of this Agreement and the
consummation of the transactions contemplated by this Agreement by
the Company have been duly authorized by all necessary corporate
action on the part of the Company, subject only to the required
receipt of the Company Stockholder Approval to the extent required
by applicable law. This Agreement has been duly executed and
delivered by the Company and constitutes the valid and binding
obligation of the Company, enforceable in accordance with its
terms.
(b) The execution and
delivery of this Agreement by the Company do not, and the
consummation by the Company of the transactions contemplated by
this Agreement shall not, (i) conflict with, or result in any
violation or breach of, any provision of the Certificate of
Incorporation or By-laws of the Company or of the charter, by-laws,
or other organizational document of any Subsidiary of the Company,
(ii) conflict with, or result in any violation or breach of,
or constitute (with or without notice or lapse of time, or both) a
default (or give rise to a right of termination, cancellation or
acceleration of any obligation or loss of any material
13
benefit) under, require a
consent or waiver under, constitute a change in control under,
require the payment of a penalty under or result in the imposition
of any mortgage, security interest, pledge, lien, charge or
encumbrance of any nature (“Liens”) on the
Company’s or any of its Subsidiary’s assets under, any
of the terms, conditions or provisions of any note, bond, mortgage,
indenture, lease, license, contract or other agreement, instrument
or obligation to which the Company or any of its Subsidiaries is a
party or by which any of them or any of their properties or assets
may be bound, or (iii) subject to obtaining the Company
Stockholder Approval (to the extent required by applicable law) and
subject to the consents, approvals and authorizations specified in
clauses (i) through (v) of Section 4.4(c) having
been obtained prior to the Effective Time and all filings and
notifications described in Section 4.4(c) having been made and
the waiting period (and any extension thereof) under the
Hart-Scott-Rodino Act having terminated or expired prior to
Effective Time, conflict with or violate any permit, concession,
franchise, license, judgment, injunction, order, decree, statute,
law, ordinance, rule or regulation applicable to the Company or any
of its Subsidiaries or any of its or their properties or assets,
except in the case of clauses (ii) and (iii) of this
Section 4.4(b) for any such conflicts, violations, breaches,
rights of termination, Liens, penalties, defaults, terminations,
cancellations, accelerations or losses that have not had, and would
not reasonably be expected to result in, a Company Material Adverse
Effect. Section 4.4(b) of the Company Disclosure Schedule
lists all consents, waivers and approvals under any of the
Company’s or any of its Subsidiaries’ agreements,
licenses or leases required to be obtained in connection with the
consummation of the transactions contemplated hereby, the absence
of which has not had, and would not reasonably be expected to
result in, a Company Material Adverse Effect.
(c) No consent, approval,
license, permit, order or authorization of, or registration,
declaration, notice or filing with, any foreign or domestic court,
arbitrational tribunal, administrative agency or commission or
other governmental, regulatory or administrative authority, agency,
commission or instrumentality or any stock market or stock exchange
on which shares of Company Common Stock are listed for trading (a
“Governmental Entity”) is required by or with respect
to the Company or any of its Subsidiaries in connection with the
execution and delivery of this Agreement by the Company or the
consummation by the Company of the transactions contemplated by
this Agreement, except for (i) the pre-merger notification
requirements under the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended (the “HSR Act”), (ii) the
filing of the Certificate of Merger with the Delaware Secretary of
State and appropriate corresponding documents with the appropriate
authorities of other states in which the Company is qualified as a
foreign corporation to transact business, (iii) the filing of
the Schedule TO, Offer Documents, Schedule 14D-9 and (if required
by applicable law) the proxy or information statement (the
“Proxy Statement”) with respect to the Company
Stockholders Meeting (as defined below) with the SEC in accordance
with the Exchange Act, (iv) the filing of such reports,
schedules or materials under Section 13 of or Rule 14a-12
under the Exchange Act and materials under Rule 165 and Rule 425
under the Securities Act as may be required in connection with this
Agreement and the transactions contemplated hereby, (v) such
consents, approvals, orders, authorizations, registrations,
declarations, notices and filings as may be required under
applicable state securities laws, the rules and regulations of the
Nasdaq Stock Market and the U.S. Federal Food, Drug, and Cosmetic
Act, as amended, and (vi) such other consents, licenses,
permits, orders, authorizations, filings, approvals and
registrations which, if not obtained or made, have not had, and
would not reasonably be expected to result in, a Company Material
Adverse Effect.
(d) To the extent stockholder
approval is required by applicable law, the affirmative vote for
adoption of the Company Voting Proposal by the holders of a
majority of the outstanding shares of Company Common Stock on the
record date for the meeting of the Company’s stockholders to
consider the Company Voting Proposal is the only vote of the
holders of any class or series of the Company’s capital stock
or other securities necessary for the adoption of this Agreement
and for the consummation by the Company of the other transactions
contemplated by this Agreement. There are no bonds, debentures,
notes or other indebtedness of the Company having the right to vote
(or convertible into, or exchangeable for, securities having the
right to vote) on any matters on which stockholders of the Company
may vote.
14
4.5 SEC Filings; Financial
Statements; Information Provided .
(a) The Company has filed all
registration statements, forms, reports, certifications and other
documents required to be filed by the Company with the SEC since it
became an SEC reporting company, and has made available to the
Parent copies of all registration statements, forms, reports,
certifications and other documents filed by the Company with the
SEC since January 1, 2005, including all certifications and
statements required by (i) Rule 13a-14 or 15d-14 of the
Exchange Act or (ii) 18 U.S. C. §1350 (Section 906 of the
Sarbanes-Oxley Act of 2002 (the “Sarbanes Act”). All
such registration statements, forms, reports, certifications and
other documents (including those that the Company may file after
the date hereof until the Closing) are referred to herein as the
“Company SEC Documents.” The Company has made available
to the Parent copies of all comment letters received by the Company
from the staff of the SEC since January 1, 2005 and all
responses to such comment letters by or on behalf of the Company.
The Company SEC Documents (x) were or will be filed on a
timely basis, (y) at the time filed (or as of the date of the
last amendment thereof, if any such Company SEC Document filed
prior to the date hereof was amended after the filing and prior to
the date hereof), were or will be prepared in compliance in all
material respects with the applicable requirements of the
Securities Act and the Exchange Act, as the case may be, and the
rules and regulations of the SEC thereunder applicable to such
Company SEC Documents, and (z) did not or will not at the time
they were or are filed (or as of the date of the last amendment
thereof, if any such Company SEC Document filed prior to the date
hereof was amended after the filing and prior to the date hereof)
contain any untrue statement of a material fact or omit to state a
material fact required to be stated in such Company SEC Documents
or necessary in order to make the statements in such Company SEC
Documents, in the light of the circumstances under which they were
made, not misleading. No Subsidiary of the Company is subject to
the reporting requirements of Section 13 or Section 15(d)
of the Exchange Act. As used in this Section 3.5, the term
“file” shall be broadly construed to include any manner
in which a document or information is furnished, supplied or
otherwise made available to the SEC.
(b) Each of the consolidated
financial statements (including, in each case, any related notes
and schedules) contained or to be contained in the Company SEC
Documents at the time filed (i) complied or will comply as to
form in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC
with respect thereto (including, without limitation, Regulation
S-X), (ii) were or will be prepared in accordance with United
States generally accepted accounting principles
(“GAAP”) applied on a consistent basis throughout the
periods involved and at the dates involved (except as may be
indicated in the notes to such financial statements or, in the case
of unaudited statements, as permitted by the SEC on Form 10-Q under
the Exchange Act), and (iii) fairly presented or will fairly
present the consolidated financial position of the Company and its
Subsidiaries as of the dates thereof and the consolidated results
of its operations and cash flows for the periods indicated,
consistent with the books and records of the Company and its
Subsidiaries, except that the unaudited interim financial
statements were or are subject to normal and recurring year-end
adjustments which were not or will not be material in amount or
effect. The consolidated, unaudited balance sheet of the Company as
of June 30, 2007 is referred to herein as the “Company
Balance Sheet.”
(c) To the knowledge of the
Company, PricewaterhouseCoopers LLP, the Company’s current
auditors, is and has been at all times since its engagement by the
Company (x) “independent” with respect to the
Company within the meaning of Regulation S-X and (y) in
compliance with subsections (g) through (l) of
Section 10A of the Exchange Act (to the extent applicable) and
the related rules of the SEC and the Public Company Accounting
Oversight Board.
(d) The information to be
supplied by or on behalf of the Company for inclusion or
incorporation by reference in the Schedule TO or the Offer
Documents, on the date the Schedule TO is filed with the SEC and on
the date the Offer Documents are first published, sent or given to
stockholders of the Company, shall comply in all material respects
with the provisions of applicable securities laws and shall not
contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in
order to make the statements therein not misleading. The Proxy
Statement (if required) to be sent to the stockholders of the
Company in connection with the Company Stockholders Meeting, on the
date
15
the Proxy Statement is first
published, sent or given to stockholders of the Company and at the
time of the Company Stockholders Meeting, shall comply in all
material respects with the provisions of applicable securities laws
and shall not contain any statement which, at such time and in
light of the circumstances under which it shall be made, is false
or misleading with respect to any material fact, or omit to state
any material fact necessary in order to make the statements made in
the Proxy Statement not false or misleading; or omit to state any
material fact necessary to correct any statement in any earlier
communication with respect to the solicitation of proxies for the
Company Stockholders Meeting which has become false or misleading;
provided that no representation or warranty is made pursuant to
this Section 4.4(c) with respect to any written information
provided by or on behalf of the Parent or the Purchaser for
inclusion in the Proxy Statement.
4.6 No Undisclosed
Liabilities . Neither the Company nor any of its Subsidiaries
has any obligations or liabilities (whether or not accrued,
contingent or otherwise, and whether or not required to be
reflected in financial statements in accordance with GAAP), except
for: (i) liabilities disclosed in the financial statements
contained in the Designated SEC Documents; (ii) liabilities
incurred in the ordinary course of business since the date of the
Company Balance Sheet; (iii) liabilities resulting from the
Company’s compliance with clauses (a) through
(y) of Section 6.1; (iv) investment banking,
accounting and legal fees incurred by the Company in connection
with the negotiation, execution and delivery of this Agreement; and
(v) liabilities that have not had, and would not reasonably be
expected to result in, a Company Material Adverse
Effect.
4.7 Absence of Certain
Changes or Events . Since the date of the Company Balance
Sheet, the Company and its Subsidiaries have conducted their
respective businesses only in the Ordinary Course of Business and,
since such date and up to and including the date of this Agreement,
there has not been (i) any change, event, circumstance,
development or effect that has had, or would reasonably be expected
to result in, a Company Material Adverse Effect; or (ii) any
other action or event that would have required the consent of the
Parent pursuant to Section 6.1 of this Agreement had such
action or event occurred after the date of this
Agreement.
4.8 Taxes .
(a) Each of the Company and
the Subsidiaries has properly filed on a timely basis all Tax
Returns that it was required to file, except where the failure to
properly file on a timely basis has not had, and would not
reasonably be expected to result in, a Company Material Adverse
Effect, and all such Tax Returns were true, correct and complete
except where the failure of such Tax Returns to be true, correct
and complete has not had, and would not reasonably be expected to
result in, a Company Material Adverse Effect. Each of the Company
and the Subsidiaries has paid on a timely basis all Taxes that were
due and payable, except where failure to so pay on a timely basis
has not had, and would not reasonably be expected to result in, a
Company Material Adverse Effect. To the Company’s knowledge,
neither the Company nor any Subsidiary (i) has any actual or
potential material liability under Treasury Regulations
Section 1.1502-6 (or any comparable or similar provision of
federal, state, local or foreign law), as a transferee or
successor, pursuant to any contractual obligation, or otherwise for
any Taxes of any person other than the Company or any Subsidiary,
or (ii) is a party to or bound by any material Tax indemnity,
Tax sharing, Tax allocation or similar agreement (other than such
an agreement exclusively between or among the Company and its
Subsidiaries), limited in each case to Taxes imposed on net or
gross income. To the Company’s knowledge, all Taxes that the
Company or any Subsidiary was required by law to withhold or
collect have been duly withheld or collected and, to the extent
required, have been properly paid to the appropriate Governmental
Entity.
(b) The Company has delivered
or made available to the Parent (i) complete and correct
copies of all Tax Returns of the Company and any Subsidiary
relating to Taxes for all taxable periods for which the applicable
statute of limitations has not yet expired, and (ii) complete
and correct copies of all private letter rulings, revenue agent
reports, information document requests, notices of proposed
deficiencies, deficiency notices, protests, petitions, closing
agreements, settlement agreements, pending ruling requests and any
similar documents submitted by, received by, or agreed to by or on
behalf of the Company or any
16
Subsidiary relating to Taxes
for all taxable periods for which the statute of limitations has
not yet expired. To the Company’s knowledge, no examination
or audit of any Tax Return of the Company or any Subsidiary by any
Governmental Entity is currently in progress. Neither the Company
nor any Subsidiary has waived any statute of limitations with
respect to Taxes or agreed to extend the period for assessment or
collection of any Taxes which waiver or agreement is still in
effect.
(c) Except for liens and
other encumbrances that have not had, and would not reasonably be
expected to result in, a Company Material Adverse Effect, there are
no liens or other encumbrances with respect to Taxes upon any of
the assets or properties of the Company or any Subsidiary, other
than with respect to Taxes not yet due and payable or being
contested in good faith.
(d) Neither the Company nor
any Subsidiary has made any payment, is obligated to make any
payment, or is a party to any agreement that could obligate it to
make any payment that may be treated as an “excess parachute
payment” under Section 280G of the Code (without regard
to Section 280G(b)(4) of the Code).
(e) There is no limitation on
the utilization by either the Company or any Subsidiary of its net
operating losses, built-in losses, Tax credits, or similar items
under Sections 382, 383, or 384 of the Code or comparable
provisions of foreign state or local law (other than any such
limitation arising as a result of the consummation of the
transactions contemplated by this Agreement).
(f) Neither the Company nor
any Subsidiary has distributed to its shareholders or security
holders stock or securities of a controlled corporation, nor has
stock or securities of the Company or any Subsidiary been
distributed, in a transaction to which Section 355 of the Code
applies (i) in the two years prior to the date of this
Agreement or (ii) in a distribution that could otherwise
constitute part of a “plan” or “series of related
transactions” (within the meaning of Section 355(e) of
the Code) that includes the transactions contemplated by this
Agreement.
(g) As used in this
Agreement:
(i) “Taxes” shall
mean any and all taxes, charges, fees, levies or other similar
assessments or liabilities in the nature of a tax, including,
without limitation, income, gross receipts, ad valorem, premium,
value-added, net worth, capital stock, capital gains, documentary,
recapture, alternative or add-on minimum, disability, estimated,
registration, recording, excise, real property, personal property,
sales, use, license, lease, service, service use, transfer,
withholding, employment, unemployment, insurance, social security,
business license, business organization, environmental, workers
compensation, payroll, profits, severance, stamp, occupation,
windfall profits, customs, duties, franchise and other taxes of any
kind whatsoever imposed by the United States of America or any
state, local or foreign government, or any agency or political
subdivision thereof, and any interest, fines, penalties,
assessments or additions to tax imposed with respect to such items
or any contest or dispute thereof, and
(ii) “Tax
Returns” shall mean any and all reports, returns, or
declarations relating to Taxes filed or required to be filed with
any taxing authority, including any schedule or attachment thereto,
including any amendment thereof.
4.9 Owned and Leased Real
Properties .
(a) Neither the Company nor
any of its Subsidiaries owns or has ever owned any real
property.
(b) The Company has made
available to the Parent a complete and accurate list of all real
property leased, subleased or licensed by the Company or any of its
Subsidiaries (collectively “Company Leases”) and the
location of the premises. Neither the Company nor any of its
Subsidiaries nor, to the Company’s knowledge, any other party
to any Company Lease, is in default under any of the Company
Leases, and except where the existence of such defaults,
individually or in the aggregate, has not had, and would not
reasonably be expected to result in, a Company Material Adverse
Effect. Each of the Company Leases is in full force and effect and
is enforceable in accordance with its terms and shall not cease to
be in full force
17
and effect as a result of the
transactions contemplated by this Agreement, except for any
failures to be in full force and effect that have not had, and
would not reasonably be expected to result in, a Company Material
Adverse Effect. Neither the Company nor any of its Subsidiaries
leases, subleases or licenses any material real property to any
person other than the Company and its Subsidiaries. The Company has
provided the Parent with complete and accurate copies of all
Company Leases.
4.10 Intellectual
Property .
(a) The Company and its
Subsidiaries own, license, sublicense or otherwise possess legally
enforceable rights to use all material Intellectual Property
necessary to conduct the business of the Company and its
Subsidiaries, taken as a whole, as currently conducted (in each
case excluding generally commercially available, off-the-shelf
software programs). For purposes of this Agreement, the term
“Intellectual Property” means all proprietary rights of
every kind and nature throughout the world owned or used by the
Company or any Subsidiary in the operation of the business of the
Company or its Subsidiaries as it is currently conducted and as it
is currently planned to be conducted, including, without
limitation, all rights and interests pertaining to or deriving from
(i) patents, patent rights, patent applications (including all
provisionals, reissues, reexaminations, revisions, divisionals,
continuations, continuing applications, continuations-in-part and
extensions of any patent or patent application), inventions,
discoveries, improvements, innovations, industrial designs, and all
applications for registration of the foregoing;
(ii) copyrights, registrations and applications for
copyrights, works, derivative works, software (including, without
limitation, all executables, libraries, controls and source code),
software documentation, database rights, mask works, domain names,
domain name registrations, web sites, web pages, moral rights,
rights of privacy and publicity, and all applications for
registration of the foregoing; (iii) trade secrets, know-how,
processes, methods, data, formula, and information (including,
without limitation, ideas, research and development, formulas,
compositions and techniques, data, designs, drawings,
specifications, customer and supplier lists, pricing and cost
information, business and marketing plans and proposals,
documentation and manuals) (collectively, “Trade
Secrets”); and (iv) trademarks, service marks, trade
names, logos, designs, brand names, trade dress, and slogans
(including, without limitation, the name of the Company and each
Subsidiary and any fictitious names used by the Company or any
Subsidiary) and all goodwill associated with any of the foregoing,
and all applications for registration of the foregoing.
(b) The execution and
delivery of this Agreement by the Company and the consummation by
the Company of the Merger will not result in the breach of, or
create on behalf of any third party the right to terminate or
modify, (i) any license, sublicense or other agreement
relating to any Intellectual Property owned by the Company that is
material to the business of the Company and its Subsidiaries, taken
as a whole, as currently conducted (the “Company Intellectual
Property”), or (ii) any license, sublicense and other
agreement as to which the Company or any of its Subsidiaries is a
party and pursuant to which the Company or any of its Subsidiaries
is authorized to use any third party Intellectual Property that is
material to the business of the Company and its Subsidiaries, taken
as a whole, as currently conducted, excluding generally
commercially available, off-the-shelf software programs.
(c) All patents, patent
applications, trademark and service mark applications and
registrations for trademarks, service marks, copyrights and other
forms of Intellectual Property included in the Company
Intelle
|